Key Metrics of Crescent Chemicals
About Crescent Chemicals
Sectors
Company details
Operational Areas of Crescent Chemicals
Company summary
Entity details
Compliance
Industry classification
Financials, ratios and risk analysis
Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.
Sign in to continue See plans & pricingFiling compliance
Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.
Vendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Credit ratings
WatchLiquidity assessed as Stretched
Rating history
Rating actions
| Date | Agency | Action | Long term | Short term | Outlook | Rated amount | Rationale |
|---|---|---|---|---|---|---|---|
| 20 May 2026 | ICRA | Reaffirmed | BB+ | A4+ | Stable | ₹10.0 Cr | View |
Could lead to an upgrade
ICRA could upgrade the ratings if the Crescent Group demonstrates a sustained improvement in its operating profitability, debt coverage metrics, and
Could lead to a downgrade
Pressure on the ratings could arise if the Crescent Group demonstrates a sustained decline in revenue and margin, or if a large debt-funded capex or a stretch in the working capital intensity further weakens its
Agency-reported financials (ICRA, 20 May 2026)
| Metric | FY2024 | FY2025 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating income | ₹1,590 Cr | ₹2,178 Cr | ₹55.80 Cr | ₹55.40 Cr |
| PAT | ₹6.40 Cr | ₹7.20 Cr | ₹1.40 Cr | ₹1.10 Cr |
| OPBDITA/OI (%) | 1.4% | 1.4% | 0.7% | 1.6% |
| PAT/OI (%) | 0.4% | 0.3% | 2.5% | 2.0% |
| Total debt/OPBDITA (times) | 9.50× | 9.60× | 9.10× | 4.20× |
| Interest coverage (times) | 1.10× | 1.00× | 0.50× | 1.10× |
| Revenue growth (YoY) | — | 37.0% | −97.4% | −0.7% |
| EBITDA (margin × income) | ₹22.26 Cr | ₹30.50 Cr | ₹0.39 Cr | ₹0.89 Cr |
| Implied total debt (debt/EBITDA × EBITDA) | ₹211 Cr | ₹293 Cr | ₹3.55 Cr | ₹3.74 Cr |
| Implied interest cost (EBITDA ÷ coverage) | ₹20.24 Cr | ₹30.50 Cr | ₹0.78 Cr | ₹0.81 Cr |
Borrowings & rated debt
Facility mix
Rated facilities
| Facility | Type | Previous | Current | Change | Rating | Action | Agency |
|---|---|---|---|---|---|---|---|
| Long-term/Short-term-Non-fund based-Others | Non-fund based limits | ₹10.0 Cr | ₹10.0 Cr | 0.0% | BB+ / A4+ (Stable) | Reaffirmed | ICRA |
Credit assessment · Cement
CARE Ratings’ Criteria for Rating Cement Companies (Sep 2024) · Standalone accounts · FY 2024-25
Ratios, pillar scores and the indicative rating are part of Premium.
Rating status
| Default | No default on record |
| Issuer cooperation | Cooperating |
| Credit enhancement | None – standalone rating |
| Next action stable or better (model) | 37% |
| Information on file | 33% · missing: Audited financial statements (last 18 months), Annual results history (3+ years), Liquidity position, Capex / investment plans, Auditor details, Shareholding pattern |
Indicative assessment from public data using the published methodology factors; not a credit rating.
Borrowing & funding lifecycle
- Credit outlook model: 36% chance the next rating action is stable or better
- Current rating BB+ (below investment grade)
- Interest coverage 1.1×
Rated limits by facility
Timeline
From the report
The liquidity profile is further characterised by limited buffer in sanctioned limits and reliance on short -term borrowings.
From the report
The Group has also availed a term loan of ~Rs. 21 crore towards acquisition of an office property (~Rs. 25 crore), with the balance funded through sale proceeds of the Baroda manufacturing facility.
From the report
The resultant repayment obligation of ~Rs. 0.37 crore per month (from February 2026 onwards) is expected to be supported by rental income of ~Rs. 0.65 crore per month from the leased office property.
Lender names, bank charges and audited borrowings are part of Premium.
Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.
Registered office and contact
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Crescent Chemicals
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
 Apollo Tyres |
Polymers & Petrochemicals · Cement, Building Materials & Polymers | apollotyres.com | 1972 | Ernakulam, India |
 Tata Chemicals |
Polymers & Petrochemicals · Cement, Building Materials & Polymers | tatachemicals.com | 1939 | Mumbai, India |
 CEAT |
Polymers & Petrochemicals · Cement, Building Materials & Polymers | ceat.in | 1924 | Mumbai, India |
| Polymers & Petrochemicals · Cement, Building Materials & Polymers | haldiapetrochemicals.com | — | Kolkata, India | |
 Pidilite Industries |
Paints, Panels & Construction Chemicals · Cement, Building Materials & Polymers | pidilite.com | 1959 | Mumbai, India |
| Aarti Industries Ltd | Discovered Companies · Other Industries | — | — | Vapi, Gujarat, India |
 Atul |
Discovered Companies · Other Industries | atul.co.in | 1947 | India |
 Gujarat Fluorochemicals Limited |
Polymers & Petrochemicals · Cement, Building Materials & Polymers | gfl.co.in | 1987 | Basal, Himachal Pradesh, India |
| Jubilant Ingrevia Limited | Discovered Companies · Other Industries | — | — | Amroha, Uttar Pradesh, India |
| Sumitomo Chemical India Limited | Polymers & Petrochemicals · Cement, Building Materials & Polymers | — | — | Mumbai, Maharashtra, India |
Similar companies
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.